Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational)

PHASE2CompletedINTERVENTIONAL
Enrollment

294

Participants

Timeline

Start Date

August 12, 2014

Primary Completion Date

August 31, 2017

Study Completion Date

December 27, 2022

Conditions
Hodgkin Disease
Interventions
DRUG

Nivolumab

Specified dose on specified days

DRUG

Doxorubicin

Specified dose on specified days

DRUG

Vinblastine

Specified dose on specified days

DRUG

Dacarbazine

Specified dose on specified days

Trial Locations (38)

1090

Local Institution - 0031, Vienna

3000

Local Institution - 0014, B-leuven

6020

Local Institution - 0032, Innsbruck

9000

Local Institution - 0015, Ghent

9908

Local Institution - 0022, Hospitalet Llobregat- Barcelona

10021

Local Institution - 0005, New York

10117

Local Institution - 0037, Berlin

18103

Local Institution - 0006, Allentown

20089

Local Institution - 0035, Rozzano (milano)

20099

Local Institution - 0036, Hamburg

28222

Local Institution - 0027, Majadahonda - Madrid

29603

Local Institution - 0023, Marbella

30322

Local Institution - 0001, Atlanta

40126

Local Institution - 0019, Bologna

48201

Local Institution - 0008, Detroit

50937

Local Institution - 0033, Cologne

55905

Local Institution - 0003, Rochester

77030

Local Institution - 0007, Houston

80131

Local Institution - 0020, Napoli

89081

Local Institution - 0034, Ulm

90048

Local Institution - 0030, Los Angeles

90095

Local Institution - 0009, Los Angeles

02215

Local Institution - 0002, Boston

Local Institution - 0025, Boston

Local Institution - 0041, Boston

07601

Local Institution - 0047, Hackensack

07920

Local Institution - 0040, Basking Ridge

37232-6307

Local Institution - 0004, Nashville

V5Z 4E6

Local Institution - 0046, Vancouver

M5G 2M9

Local Institution - 0042, Toronto

128 08

Local Institution - 0044, Prague

1066 CX

Local Institution - 0016, Amsterdam

9713 GZ

Local Institution - 0038, Groningen

3584 CX

Local Institution - 0017, Utrecht

SA2 8QA

Local Institution - 0043, Swansea

M20 4BX

Local Institution - 0012, Withington

OX3 7LJ

Local Institution - 0026, Oxford

SM2 5PT

Local Institution - 0013, Sutton

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY